noteworthy development. A question in the survey concerning acquisition strategy asks whether respondents prefer de novo, turnarounds or established, cash-flow- ing surgery centers. “We had a healthy response for de novo at 37 percent,” he says. “This may be reflective of the com- petition for acquisitions. A de novo strat- egy is an effective approach for growth if you want to avoid competing for existing surgery centers or believe acquiring such ASCs may prove more difficult.” Going forward, Muller anticipates a

Market collaboration on the rise BY ROBERT KURTZ ASC Valuation Multiples


he ASC industry is a hotbed of transaction activity. That activ-

ity is helping to drive up the value of facilities and likely spurring the devel- opment of new centers.

Those are some of the conclusions

drawn from HealthCare Appraisers’ 2019 ASC Valuation Survey. Health- Care Appraisers conducted the sur- vey in collaboration with ASCA. The survey asks management companies, health systems and ASC investment bankers and business brokers about trends in ASC value. Respondents to this year’s survey collectively own or manage more than 1,000 ASCs. In a report full of data and insights, a

few trends stand out to Matthew Muller, director of HealthCare Appraisers in Denver, Colorado. “One of the most significant takeaways is that there was a notable increase in valuation multiples in 2018. Controlling interests increased markedly as compared to annual mul- tiple growth in recent prior years.” The average multiple observed for controlling interests in single-specialty

ASCs increased from 6.6x in last year’s survey to about 7.1x in this year’s sur- vey. For multi-specialty ASCs, con- trolling interests increased from about 7.3x to 8.0x.

On the single-specialty side, contrib- uting to this increasing multiple is the continued investing in ASCs by private equity firms, Muller says. “ASCs, such as

few trends that are likely to have signifi- cant effects on future survey results. “We are watching developments concern- ing certificate of need (CON) closely. Some states, such as Florida, North Car- olina and Alaska, are looking to repeal or reform their CON law. If any changes occur that affect ASCs, one would expect to see more de novo development in those states.” Any changes to CON law would

likely also affect the value of existing ASCs, he adds. “Our survey shows there is typically a premium paid of around 0.5x to 1.0x to those ASCs that hold a CON. If a CON is no longer required, then we would expect to see a slight decrease in multiples.” Another development that Muller

those performing ophthalmology, pain management and gastroenterology, are seeing an increase in private equity investing, typically in conjunction with investment in physician practices.” Helping boost multiples in all ASC

types is increased interest from health systems, Muller says. “As more acute cases shift from the hospital inpatient setting to the outpatient setting, these health systems want to make sure they remain involved. Partnering with a local ASC, if the opportunity arises, allows them to avoid losing out entirely on that case shift.”

As these and other trends indicate, acquisition interest remains high, Muller says, and that interest has resulted in a


expects will influence the ASC market is growing collaboration between corpo- rate players. “Your typical joint venture ASC pairs together physicians with a health system or physicians with a man- agement company. We are starting to see more of these corporate entities work- ing together in three-way joint ventures, with health systems, management com- panies and physicians partnering around an ASC. This is another example of when entities decide it may be easier to collaborate than directly compete.” To download a copy of the 2019

ASC Valuation Survey, go to www. valuation-surveys/2019-asc-valuation- survey.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56